Literature DB >> 18626426

The role of microRNAs in primary liver cancer.

Heike Varnholt1.   

Abstract

Small RNA molecules such as microRNAs, for many years considered to be superfluous genomic material, are now known to play important regulatory roles in apoptosis, cell proliferation and differentiation, angiogenesis and thus in carcinogenesis. Primary liver carcinomas such as hepatocellular carcinomas, cholangiocarcinomas and mixed variants show a rising incidence with high mortality among affected patients but lack effective targeted therapies except the new multiple kinase inhibitor Sorafenib. This review elucidates the recent contributions of miRNA gene expression analyses to a better understanding of the complex molecular interactions in liver carcinogenesis and highlights their future promise to provide novel tools for improved diagnostics, more accurate prognostic assessment and tailored molecular therapies in liver cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626426

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  25 in total

Review 1.  Emerging role of microRNAs in liver diseases.

Authors:  Shashi Bala; Miguel Marcos; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

2.  Molecular mechanisms of cholangiocarcinoma.

Authors:  Giammarco Fava
Journal:  World J Gastrointest Pathophysiol       Date:  2010-04-15

3.  A micro-RNA expression signature for human NAFLD progression.

Authors:  Yan Guo; Yanhua Xiong; Quanghu Sheng; Shilin Zhao; Julia Wattacheril; Charles Robb Flynn
Journal:  J Gastroenterol       Date:  2016-02-13       Impact factor: 7.527

4.  MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6.

Authors:  Yong Zu; Yanhong Yang; Jiyun Zhu; Xiaobo Bo; Shuangxing Hou; Bo Zhang; Jiangfeng Qiu; Jing Zheng
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

Review 5.  Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Yves Dittmar; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

6.  Altered microRNA Expression Patterns in Hepatoblastoma Patients.

Authors:  Armando Magrelli; Gianluca Azzalin; Marco Salvatore; Mara Viganotti; Fabrizio Tosto; Teresa Colombo; Rita Devito; Alessandra Di Masi; Antonio Antoccia; Stefano Lorenzetti; Francesca Maranghi; Alberto Mantovani; Caterina Tanzarella; Giuseppe Macino; Domenica Taruscio
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

7.  Inhibiting the proliferation and metastasis of hilar cholangiocarcinoma cells by blocking the expression of vascular endothelial growth factor with small interfering RNA.

Authors:  Ke Xiao; Zhengxiao Ouyang; Hui-Huan Tang
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

8.  Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma.

Authors:  Mengzi Zhang; Xiaoju Zhou; Bo Wang; Bryant C Yung; Ly J Lee; Kalpana Ghoshal; Robert J Lee
Journal:  J Control Release       Date:  2013-04-06       Impact factor: 9.776

9.  MiR-221 promotes IgE-mediated activation of mast cells degranulation by PI3K/Akt/PLCγ/Ca(2+) pathway.

Authors:  Hong Xu; Li-Na Gu; Qian-Yuan Yang; De-Yu Zhao; Feng Liu
Journal:  J Bioenerg Biomembr       Date:  2016-04-25       Impact factor: 2.945

10.  Gene regulation is governed by a core network in hepatocellular carcinoma.

Authors:  Zuguang Gu; Chenyu Zhang; Jin Wang
Journal:  BMC Syst Biol       Date:  2012-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.